Risk Factors for CVD More Common in Postmenopausal Women Who Survived Breast Cancer
Researchers compared the development of specific CVD risk factors in postmenopausal women who survived breast cancer and women without history of breast cancer.
Breast Cancer
Research Examines Breast Cancer Susceptibility Genes in Hispanic Women and Other Diverse Populations
The presence of CHEK2 or PALB2 variants in Hispanic women is enough to warrant the addition of an annual breast MRI, said study authors.
CAR-T Therapy Injected Directly Into Chest Cavity Shows Early Promise in Pleural Cancers
Early results from a phase 1 clinical trial of CAR T cells administered directly into the chest cavity for the treatment of pleural cancers has shown low toxicity and high efficacy.
Fragmentation Pattern of Cell-Free DNA Can Reveal Cancer, Even at Early Stages
Machine learning algorithm detected 7 types of cancer in liquid biopsy and identified tissue of disease origin.
Solving the Obesity Paradox in Oncology
One potentially revolutionary hypothesis relates to the evolutionary processes involved in oncogenesis.
Could Copy Number Detection Solve the Riddle of EGFR Inhibitors in TNBC?
An exceptional response to cetuximab in a patient with EGFR-amplified triple-negative breast cancer suggests EGFR copy number may help identify responders.
Physicians Unaware of Breast Density Laws, Cancer Risk
Physicians need more education about breast density and breast cancer screening.
Prospective Evidence Links Textured Breast Implants to Rare Lymphoma
The risk of breast implant-associated anaplastic large cell lymphoma may be higher than previously reported for women who receive textured implants, according to researchers.
Breastfeeding Duration May Influence Markers of Inflammation and Proliferation in Breast Tissue of Healthy Parous Women
Morphologic features were examined to identify markers of inflammation, and proliferation index was assessed using Ki67 immunostaining.
Drug Combo Slows Progression in Advanced Breast Cancer
Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients with PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer.
